loadpatents
name:-0.029698133468628
name:-0.024062156677246
name:-0.00052785873413086
Hickey; Deirdre Mary Bernadette Patent Filings

Hickey; Deirdre Mary Bernadette

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hickey; Deirdre Mary Bernadette.The latest application filed is for "novel compounds".

Company Profile
0.23.27
  • Hickey; Deirdre Mary Bernadette - Stevenage GB
  • Hickey; Deirdre Mary Bernadette - Essex GB
  • HICKEY; Deirdre Mary Bernadette - Harlow GB
  • Hickey; Deirdre Mary Bernadette - Saffron Walden GB
  • Hickey, Deirdre Mary Bernadette - Hertfordshire GB
  • Hickey; Deirdre Mary Bernadette - Welwyn GB2
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds
Grant 9,408,851 - Borthwick , et al. August 9, 2
2016-08-09
Compounds
Grant 9,266,841 - Hickey , et al. February 23, 2
2016-02-23
Novel Compounds
App 20160030442 - Borthwick; Alan David ;   et al.
2016-02-04
Novel Compounds
App 20150157640 - Borthwick; Alan David ;   et al.
2015-06-11
Novel Compounds
App 20150045375 - HICKEY; Deirdre Mary Bernadette ;   et al.
2015-02-12
Compounds
Grant 8,871,775 - Hickey , et al. October 28, 2
2014-10-28
Compounds
Grant 8,742,099 - Borthwick , et al. June 3, 2
2014-06-03
Novel Compounds
App 20130253188 - Borthwick; Alan David ;   et al.
2013-09-26
Substituted diketopiperazines as oxytocin antagonists
Grant 8,541,579 - Borthwick , et al. September 24, 2
2013-09-24
Substituted Diketopiperazines As Oxytocin Antagonists
App 20130131338 - Borthwick; Alan David ;   et al.
2013-05-23
Substituted diketopiperazines as oxytocin antagonists
Grant 8,367,673 - Borthwick , et al. February 5, 2
2013-02-05
Novel Compounds
App 20120202811 - Borthwick; Alan David ;   et al.
2012-08-09
Novel Compounds
App 20120172378 - HICKEY; Deirdre Mary Bernadette ;   et al.
2012-07-05
Compounds
Grant 8,202,864 - Borthwick , et al. June 19, 2
2012-06-19
Novel Compounds
App 20110152262 - Borthwick; Alan David ;   et al.
2011-06-23
Compounds
Grant 7,919,492 - Borthwick , et al. April 5, 2
2011-04-05
Novel Compounds
App 20100305127 - Borthwick; Alan David ;   et al.
2010-12-02
5,6-trimethylenepyrimidin-4-one compounds
Grant 7,652,019 - Hickey , et al. January 26, 2
2010-01-26
Pyrimidine compounds
Grant 7,638,520 - Hickey , et al. December 29, 2
2009-12-29
Novel compounds
App 20090247541 - Borthwick; Alan David ;   et al.
2009-10-01
Substituted Diketopiperazines As Oxytocin Antagonists
App 20090186867 - Borthwick; Alan David ;   et al.
2009-07-23
5,6-Trimethylenepyrimidin-4-one compounds
App 20090170877 - Hickey; Deirdre Mary Bernadette ;   et al.
2009-07-02
Piperazinediones as oxytocin receptor antagonists
Grant 7,550,462 - Borthwick , et al. June 23, 2
2009-06-23
Novel Compounds
App 20090118313 - Hickey; Deirdre Mary Bernadette ;   et al.
2009-05-07
Substituted diketopiperazines as oxytocin antagonists
Grant 7,514,437 - Borthwick , et al. April 7, 2
2009-04-07
Pyrimidinone derivatives and their use in the treatment of atherosclerosis
Grant 7,462,620 - Hickey , et al. December 9, 2
2008-12-09
Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
Grant 7,314,742 - MacPhee , et al. January 1, 2
2008-01-01
Piperazinediones as Oxytocin Receptor Antagonists
App 20070254888 - Borthwick; Alan David ;   et al.
2007-11-01
Pyridinone derivatives for treatment of atherosclerosis
Grant 7,235,566 - Hickey , et al. June 26, 2
2007-06-26
Pyrimidine compounds
App 20070123549 - Hickey; Deirdre Mary Bernadette ;   et al.
2007-05-31
Pyrimidinone derivatives and their use in the treatment of atherosclerosis
Grant 7,169,924 - Elliott , et al. January 30, 2
2007-01-30
Pyrimidinone Derivatives and Their Use in the Treatment of Atherosclerosis
App 20060241126 - Elliott; Richard Leonard ;   et al.
2006-10-26
Pyrimidinone compounds
Grant 7,115,616 - Fenwick , et al. October 3, 2
2006-10-03
Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
Grant 7,045,329 - MacPhee , et al. May 16, 2
2006-05-16
Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
App 20060040371 - MacPhee; Colin Houston ;   et al.
2006-02-23
Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
App 20050260731 - MacPhee, Colin Houston ;   et al.
2005-11-24
Pyrimidine compounds
Grant 6,953,803 - Hickey , et al. October 11, 2
2005-10-11
Substituted diketopiperazines as oxytocin antagonists
App 20050148572 - Borthwick, Alan David ;   et al.
2005-07-07
Pyridone, pyridazone and triazone derivatives as lp-pla2 inhibitors
App 20050020832 - Fell, Stephen Christopher Martin ;   et al.
2005-01-27
Pyridinone derivatives for treatment of atherosclerosis
App 20050014793 - Hickey, Deirdre Mary Bernadette ;   et al.
2005-01-20
Pyrimidinone compounds
App 20040167142 - Fenwick, Ashley Edward ;   et al.
2004-08-26
Novel Compounds
App 20040097525 - Hickey, Deirdre Mary Bernadette ;   et al.
2004-05-20
Pyridinone derivatives for treatment of atherosclerosis
App 20040063753 - Hickey, Deirdre Mary Bernadette ;   et al.
2004-04-01
Pyrimidinone derivatives and their use in the treatment of atherosclerosis
App 20040058941 - Elliott, Richard Leonard ;   et al.
2004-03-25
Compounds
Grant 6,649,619 - Hickey , et al. November 18, 2
2003-11-18
Pyrimidinone compounds and pharmaceutical compositions containing them
App 20020120139 - Hickey, Deirdre Mary Bernadette ;   et al.
2002-08-29
Novel compounds
App 20020103213 - Hickey, Deirdre Mary Bernadette ;   et al.
2002-08-01
Inhibition of inflammatory lipid mediators
Grant 5,663,053 - Winkler , et al. September 2, 1
1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed